PharmaceuticalsSouth Asian country grapples with sharp rise in cases over recent yearsThe number of dengue cases in India has soared elevenfold over the past two decades, according to Takeda Pharmaceutical. © ReutersTAKANORI OKABEJuly 21, 2026 23:00 JSTMUMBAI -- Indian regulators have approved Japanese drugmaker Takeda Pharmaceutical's vaccine against dengue, the country's first such vaccine, in a bid to curb the increasingly rapid spread of the disease.